Accumulated bladder wall dose and urinary toxicity 153 21. Bosma LS, Zachiu C, Ries M, Denis de Senneville B, Raaymakers BW. Quantitative investigation of dose accumulation errors from intrafraction motion in MRgRT for prostate cancer. Phys Med Biol 2021;66:65002. 22. Zachiu C, Denis de Senneville B, Willigenburg T, van der Voort van Zyp JRN, de Boer JCJ, Raaymakers BW, et al. Anatomically-adaptive multi-modal image registration for image-guided external-beam radiotherapy. Phys Med Biol 2020. 23. Willigenburg T, Zachiu C, Lagendijk JJW, van der Voort van Zyp JRN, de Boer JCJ, Raaymakers BW. Fast and accurate deformable contour propagation for intrafraction adaptive magnetic resonance-guided prostate radiotherapy. Phys Imaging Radiat Oncol 2022;21:62–5. 24. Henderson DR, Murray JR, Gulliford SL, Tree AC, et al. An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity. Clin Oncol (R Coll Radiol) 2018;30:539–47. 25. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32–5. 26. Smith GA, Dunlop A, Barnes H, Herbert T, Lawes R, Mohajer J, et al. Bladder filling in patients undergoing prostate radiotherapy on a MR-linac: The dosimetric impact. Tech Innov Patient Support Radiat Oncol 2022;21:41–5. 27. de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, van Lier ALHMW, et al. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5 T MR-Linac. Radiother Oncol 2020;151. 28. Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, et al. Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment? Int J Radiat Oncol Biol Phys 2018;100:361– 73. 29. Alongi F, Rigo M, Figlia V, Cuccia F, Giaj-Levra N, Nicosia L, et al. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: Feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment. Radiat Oncol 2020;15:1– 9. 30. Bruynzeel AME, Tetar SU, Oei SS, Senan S, Haasbeek CJA, et al. A prospective single-arm phase II study of stereotactic magnetic-resonance-guided adaptive radiotherapy for prostate cancer: Early toxicity results. Int J Radiat Oncol 2019. 31. Li S, Boyer A, Lu Y, Chen GT. Analysis of the dosesurface histogram and dose-wall histogram for the rectum and bladder. Med Phys 1997;24:1107–16. 32. Maggio A, Carillo V, Cozzarini C, Perna L, Rancati T, Valdagni R, et al. Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients. Phys Med Biol 2013;58:N115--N123. 7
RkJQdWJsaXNoZXIy MTk4NDMw